Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ricardo F. López-Villanueva"'
Autor:
Guillermo Valencia Pacheco, Yumi E. Nakazawa Ueji, Julián Ramírez Bello, Rosa E. Barbosa Cobos, Eduardo D. Jiménez Becerra, Lizbeth J. González Herrera, Gerardo J. Pérez Mendoza, Nubia A. Rivero Cárdenas, Angélica V. Angulo Ramírez, Ricardo F. López Villanueva
Publikováno v:
Journal of Immunology Research, Vol 2022 (2022)
Systemic Lupus Erythematosus (SLE) is an autoimmune disease in which genetic factors play a role in the susceptibility to develop it. Genes related to the synthesis of interferons such as TLR7 and genetics factors such as single nucleotide polymorphi
Externí odkaz:
https://doaj.org/article/a4ce03bfff1848c2b09d80bc80f79977
Autor:
Ricardo F. López-Villanueva, Guillermo Valencia-Pacheco, Rita Zapata-Vázquez, Ricardo López-Suárez, Carlos Castro-Sansores
Publikováno v:
Reumatología Clínica (English Edition). 19:106-113
Systemic lupus erythematosus (SLE) is an autoimmune with variable severity, common in Hispanic and African-American individuals.To know the clinical activity and the accumulated damage, as well as the prevalence and incidence, in a dynamic cohort of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a86056af3bc6b7bcc09b85374209fda9
https://doi.org/10.1016/j.reumae.2021.12.002
https://doi.org/10.1016/j.reumae.2021.12.002
Autor:
Ricardo F. López-Villanueva, Guillermo Valencia-Pacheco, Rita Zapata-Vázquez, Ricardo López-Suárez, Carlos Castro-Sansores
Publikováno v:
Reumatología Clínica. 19:106-113
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::205598f8b4bf4fc14dbcc9d898bf0e4e
https://doi.org/10.1016/j.reuma.2021.12.005
https://doi.org/10.1016/j.reuma.2021.12.005
Autor:
Julian Ramírez-Bello, Celi Sun, Guillermo Valencia-Pacheco, Bhupinder Singh, Rosa Elda Barbosa-Cobos, Miguel A Saavedra, Ricardo F López-Villanueva, Swapan K Nath
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0224543 (2019)
IntroductionITGAM has consistently been associated with susceptibility to systemic lupus erythematosus (SLE) in many ethnically diverse populations. However, in populations with higher Amerindian ancestry (like Yucatan) or highly admixed population (
Externí odkaz:
https://doaj.org/article/b823cb6bc26f4e378592e9c977cf6a56
Autor:
Melina González-Salazar, José Alvarez-Nemegyei, Sherlin May-Kim, Liliane Martínez-Vargas, Daniel Quintal-Gutiérrez, Ricardo F. López-Villanueva, Elda Pacheco-Pantoja
Publikováno v:
Reumatología Clínica. 16:462-467
Resumen Introduccion La asociacion entre la presencia de sobrepeso/obesidad y el estado clinico de la artritis reumatoide (AR) es un tema aun no resuelto. Objetivo Evaluar la asociacion entre el tipo de composicion corporal y el estado clinico en pac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed2cc24e71a14307a5ef376fcdb92cbe
https://doi.org/10.1016/j.reuma.2018.11.005
https://doi.org/10.1016/j.reuma.2018.11.005
Autor:
Ricardo F. López-Villanueva, Abraham Majluf-Cruz, María de la Luz Rivas-Jiménez, Alejandro Martínez, Carlos Loaiza-Cárdenas, Fedra Irazoque-Palazuelos, Roberto Reyes-Patatuchi, Leobardo Terán-Estrada, Vanesa Gordillo-Huerta, Teresa Arredondo-Garza, Ignacio Mariscal-Ramírez
Publikováno v:
Latin american journal of clinical sciences and medical technology. 1:28-34
Background. The treatment of rheumatoid arthritis (RA) has significantly improved since the introduction of biologics like rituximab. Rituximab achieves selective B lymphocyte depletion and, thereby, reduce inflammation. It has adverse reactions rela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91e0dcde5eb2588ed4a573bf45dfafa3
https://doi.org/10.34141/ljcs1446110
https://doi.org/10.34141/ljcs1446110
Autor:
Rosa Elda Barbosa-Cobos, Guillermo Valencia-Pacheco, Olga Beltrán-Ramírez, Silvia Jiménez-Morales, Carlos Alfonso Tovilla-Zárate, Mayra Jiménez-Morales, Dulce Milagro Razo-Blanco Hernández, Julian Ramírez-Bello, Luis M. Amezcua-Guerra, Fausto Sánchez-Muñoz, María Concepción Aguilera-Cartas, Isidro Alemán-Ávila, Oscar Peralta-Zaragoza, Yaneli Juárez-Vicuña, Ricardo F. López-Villanueva
Publikováno v:
Oncotarget
// Isidro Aleman-Avila 1, 2 , Mayra Jimenez-Morales 1 , Olga Beltran-Ramirez 1 , Rosa Elda Barbosa-Cobos 3 , Silvia Jimenez-Morales 4 , Fausto Sanchez-Munoz 5 , Guillermo Valencia-Pacheco 6 , Luis M. Amezcua-Guerra 5 , Yaneli Juarez-Vicuna 5 , Dulce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2175ae3ef1f9ba329a5a02b889ed9cad
http://europepmc.org/articles/PMC5696148
http://europepmc.org/articles/PMC5696148
Autor:
Ricardo F. López-Villanueva, Julian Ramírez-Bello, José Moreno, Rosa Elda Barbosa-Cobos, Olga Beltrán-Ramírez, Daniel Cadena-Sandoval, Yaneli Juárez-Vicuña, María Concepción Aguilera-Cartas, Fausto Sánchez-Muñoz, Guillermo Valencia-Pacheco, Jesús Bautista-Olvera, Luis M. Amezcua-Guerra, Daniela Josabeth López-Cano
Publikováno v:
Inflammation research : official journal of the European Histamine Research Society ... [et al.]. 66(9)
The functional PTPN22 R620W polymorphism (rs2476601) is clearly associated with susceptibility to several autoimmune diseases (ADs). However, the PTPN22 R263Q polymorphism (rs33996649) has been scarcely explored in different ADs. Here we aimed to exa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad5d80b2b6b1e198a2155a1f91868348
https://pubmed.ncbi.nlm.nih.gov/28500376
https://pubmed.ncbi.nlm.nih.gov/28500376
Autor:
Ricardo F. López-Villanueva, Adelfia Urenda-Quezada, Lilia Andrade-Ortega, Maria de los Ángeles Díaz-Ceballos, Rodolfo Rivas-Ruiz, Yaneth Barragán-Navarro, Fernando Bourget-Pietrasanta, Fedra Irazoque-Palazuelos, Roberto Hernández-Paz
Publikováno v:
Reumatología Clínica. 6:250-255
There are no controlled studies that compare the efficacy of RTX with standard treatment, such as cyclophosphamide, in patients with systemic lupus erythematosus (SLE).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bfc8cf319fdb8a59ca8b50c0ca21cab
https://doi.org/10.1016/j.reuma.2009.11.004
https://doi.org/10.1016/j.reuma.2009.11.004
Autor:
Ricardo F. López-Villanueva, Roberto Hernández-Paz, Maria de los Ángeles Díaz-Ceballos, Rodolfo Rivas-Ruiz, Yaneth Barragán-Navarro, Fernando Bourget-Pietrasanta, Fedra Irazoque-Palazuelos, Lilia Andrade-Ortega, Adelfia Urenda-Quezada
Publikováno v:
Reumatologia clinica. 6(5)
There are no controlled studies that compare the efficacy of rituximab (RTX) with standard treatment, such as cyclophosphamide, in patients with systemic lupus erythematosus (SLE). Objective The objective of this study was to compare the efficacy of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::212ea5c6c0ae52ec7f88632920099e7c
https://pubmed.ncbi.nlm.nih.gov/21794725
https://pubmed.ncbi.nlm.nih.gov/21794725